Navigation Links
Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results
Date:11/12/2009

September 30, 2008.

Research and development expense for the nine months ended September 30, 2009 was approximately $6.61 million, compared to approximately $8.84 million for the same period in 2008. The $2.23 million decrease is primarily attributable to lower Intermezzo® development costs, the majority of which were incurred prior to the submission of the Intermezzo® NDA on September 30, 2008. Research and development expense included non-cash stock compensation expense in accordance with ASC Topic 718 of approximately $391,000 for the nine months ended September 30, 2009 and approximately $192,000 for the nine months ended September 30, 2008.

General and administrative expense for the nine months ended September 30, 2009 was approximately $13.07 million, compared to approximately $5.37 million for the same period in 2008. The $7.70 million increase consists primarily of higher professional fees to operate as a public company and to negotiate our collaboration with Purdue, increased personnel costs primarily in marketing and administration, increased marketing expense as we prepared to commercialize Intermezzo® and an increase in operational expenses associated with additional office space. General and administrative expense included non-cash stock compensation expense in accordance with ASC Topic 718 of approximately $693,000 for the nine months ended September 30, 2009, as compared to approximately $268,000 for the nine months ended September 30, 2008.

Year-to-date merger-related transaction costs of approximately $2.22 million were expensed during the first quarter of 2009.

Net loss for the nine months ended September 30, 2009 was approximately $19.5 million or $1.65 per share, compared to a net loss of approximately $13.8 million or $35.93 per share for the nine months ended September 30, 2008. The weighted average shares used to calculate net loss per share were 11,764,
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Transcept Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference on November 17
2. Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12
3. Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application
4. Transcept Pharmaceuticals to Report First Quarter 2009 Results
5. Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
6. Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008
7. Biostar Pharmaceuticals, Inc. Announces Record Third Quarter 2009 Financial Results
8. Onyx Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
9. Webcast Alert: Isis Pharmaceuticals and Genzyme Corporation to Present Mipomersen Phase 3 Data in HoFH During AHA
10. Endo Pharmaceuticals and LecTec Settle Patent Dispute
11. Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... NEW YORK , Feb. 27, 2015 ... DESI are increasing in applications as their ... research firm Kalorama Information.  Kalorama Information says ... MS) is the most powerful tool in ... (mass spec; MS) through its traditional techniques ...
(Date:2/26/2015)... -- Today the National Safety Council released a ... effects of pain medications , debunking ... Oxycontin, are safer options than over-the-counter pain relievers. ... on heroin and cocaine combined," said Deborah A.P. ... medications are marketed as the Cadillac option for treating ...
(Date:2/26/2015)... , Feb. 26, 2015 Every year many ... to fight heart disease.  Nevertheless, year after year doctors ... (EKG) as the first test to determine the status ... chest pain or not, even though that technology is ... the fact that doctors know, (while most patients do ...
Breaking Medicine Technology:Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3National Safety Council: Opioid prescription painkillers have hidden, deadly side effects 2National Heart Health Month In February 2
... , SAN MATEO, Calif., Oct. 20 AlphaDetail, an ... two new features to its suite of tracking services: ... their competitive landscape by integrating secondary research with tracking ... today is managing through vast amounts of data, gathered ...
... 20 Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) announced ... Investor Conference on Monday, October 26, 2009 at 5:00 p.m. ... at the Hyatt Regency La Jolla Hotel in San Diego. ... Anadys, will provide an overview of Anadys and its clinical ...
Cached Medicine Technology:AlphaDetail Tracking Study Enhancements: The Advantage of Integration and Speed 2Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences 2
(Date:3/1/2015)... (PRWEB) March 01, 2015 Theme and ... new transition pack for Final Cut Pro ... accordion style transitions to any FCPX editors project.” Said ... our users the tools needed to easily drag and ... The user gets many different controls over the parameters ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 In a ... Fletcher of Game Change Athlete Development ... Leinert about the benefits of athlete development and player ... of the unique challenges that athletes face and how ... future success. , Fletcher became involved in athlete development ...
(Date:2/28/2015)... Morristown, NJ (PRWEB) February 28, 2015 ... Month—is a good time to remind ourselves and ... be ignored, say Atlantic NeuroSurgical Specialists (ANS). , ... (TBI), which account for 75% of TBIs. There ... word concussion may sound benign, but it is ...
(Date:2/28/2015)... For those people who are unable to ... Applied Research Foundation (Meso Foundation) will broadcast its ... at 9:30 AM. , The live broadcast is free ... be accessed through any browser on a computer or ... is a unique event that covers important treatment information ...
(Date:2/28/2015)... 28, 2015 India Network Foundation, ... visitor health insurance programs for visitors coming to the ... elderly parents traveling to the United States are suffering ... and blood pressure. These diseases are so common among ... them as medical conditions. There were 66.8 million cases ...
Breaking Medicine News(10 mins):Health News:Announcing a New Transition Pack from Pixel Film Studios, Transccordion for Final Cut Pro X 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3
... need to improve their infrastructure to prevent and manage outbreaks ... a World Health Organisation (WHO) meeting to chart a roadmap ... ,Dengue is a prevailing disease for the past two ... Pacific. ,The WHO says the frequency of ...
... New light has been shed on proteorhodopsin, the light-sensitive ... the U.S. Department of Energy’s Lawrence// Berkeley National Laboratory ... have demonstrated that when the ability to respire oxygen ... solar power to carry out vital life processes. ...
... vitamin B12, two important nutrients for the development of ... protect cognitive function// among seniors, reports a new epidemiological ... epidemiologist at the USDA HNRCA, "we found a strong ... among people 60 and older who also had adequate ...
... appearing in the February issue of Current Directions in ... mechanisms// to pass on his genes during post-copulation as ... their article, Todd Shackelford and Aaron Getz at Florida ... of males competing for fertilizations." ,For ...
... have solved a decades-old cancer mystery. "We not only ... a master switch for a tumor suppressive network that ... future," said CSHL Associate Professor Alea Mills, Ph.D. The ... issue of Cell. ,Specifically, Mills' discovery identifies ...
... A recent study finds that many seniors are still not ... seem to consume more vitamin K than younger people.,This study ... Metabolic Care. ,Sarah Booth, PhD, lab director of ... Nutrition Research Center on Aging at Tufts University (USDA HNRCA), ...
Cached Medicine News:Health News:WHO Urges Asian Countries To Improve Infrastructure To Tackle Dengue 2Health News:Shedding New Light on Proteorhodopsin 2Health News:Optimum Folate and Vitamin B12 Levels Essential for Cognitive Function in Seniors 2Health News:Males Adapt To Battle With Competing Sperm 2Health News:Scientists Discover New Gene 2Health News:Seniors Not Taking Enough Vitamin K 2
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
... Are offered as either EDTA ... binds the calcium ions and therefore ... and thrombocytes in an EDTA anticoagulated ... to 24 hours. EDTA tubes are ...
... is the most powerful, ... Easy-to-use and rich in ... with a comprehensive authoring ... delivering custom interactive multimedia ...
We offer small and large pre-gelled Surface Electrodes suitable for EMG or EGG recordings....
Medicine Products: